Literature DB >> 16237222

Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology.

Matthias Woenckhaus1, Ulrike Grepmeier, Bernhard Werner, Christian Schulz, Felix Rockmann, Peter J Wild, Georg Röckelein, Hagen Blaszyk, Marion Schuierer, Ferdinand Hofstaedter, Arndt Hartmann, Wolfgang Dietmaier.   

Abstract

Pleural effusions may result from various inflammatory, hemodynamic, or neoplastic conditions. A common diagnostic problem lies in distinguishing malignant from benign pleural effusions using routine cytological evaluation. We studied pleural fluid samples obtained from 14 patients with histologically confirmed malignancy and from 6 patients with benign pleural effusions using 12 microsatellite markers from 8 different chromosomal regions. Supernatants and cellular sediments of all 20 pleural fluid samples were analyzed. Routine cytological examination was 100% specific for malignancy but was only 57% sensitive. Microsatellite analyses of pleural fluid supernatants showed genetic alterations in tumor patients only. However, 50% of pleural effusions that were considered negative for malignancy by routine cytological analysis showed either loss of heterozygosity or microsatellite instability. The sensitivity of pleural fluid examination rose to 79% when routine cytological assessment was supplemented by molecular studies. Our data suggest that microsatellite analysis increases the sensitivity of cytological pleural fluid examination in assessing potential malignancy and that combining cytological and molecular methods may improve yield and certainty in diagnostically challenging cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237222      PMCID: PMC1888495          DOI: 10.1016/S1525-1578(10)60583-1

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  73 in total

1.  Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan.

Authors:  J S Huang; C P Chiang; S H Kok; Y S Kuo; M Y Kuo
Journal:  J Oral Pathol Med       Date:  1997-08       Impact factor: 4.253

2.  Diagnostic principles in pleural disease.

Authors:  R W Light
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

3.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

4.  LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions. Prognostic implications.

Authors:  J Sanz-Ortega; J Sanz-Esponera; T Caldes; E Gomez de la Concha; M E Sobel; M J Merino
Journal:  Pathol Res Pract       Date:  1996-12       Impact factor: 3.250

5.  Diagnosis of renal cancer by molecular urinalysis.

Authors:  C F Eisenberger; M Schoenberg; C Enger; S Hortopan; S Shah; N H Chow; F F Marshall; D Sidransky
Journal:  J Natl Cancer Inst       Date:  1999-12-01       Impact factor: 13.506

6.  Pleural cytologies in lung cancer without pleural effusions.

Authors:  S I Kjellberg; C M Dresler; M Goldberg
Journal:  Ann Thorac Surg       Date:  1997-10       Impact factor: 4.330

7.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.

Authors:  W Dietmaier; S Wallinger; T Bocker; F Kullmann; R Fishel; J Rüschoff
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

8.  p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.

Authors:  H Kohno; K Hiroshima; T Toyozaki; T Fujisawa; H Ohwada
Journal:  Cancer       Date:  1999-01-15       Impact factor: 6.860

9.  Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.

Authors:  I I Wistuba; C Behrens; S Milchgrub; D Bryant; J Hung; J D Minna; A F Gazdar
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

10.  Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears.

Authors:  H Motherby; M Kube; N Friedrichs; B Nadjari; K Knops; A Donner; B Baschiera; P Dalquen; A Böcking
Journal:  Anal Cell Pathol       Date:  1999       Impact factor: 2.916

View more
  6 in total

1.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

2.  WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Authors:  Tsung-Ming Yang; Shaw-Wei Leu; Jhy-Ming Li; Ming-Szu Hung; Chu-Huan Lin; Yu-Ching Lin; Tung-Jung Huang; Ying-Huang Tsai; Cheng-Ta Yang
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-16       Impact factor: 4.553

Review 3.  Malignant pleural effusion and algorithm management.

Authors:  Konstantinos Zarogoulidis; Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Nikolaos Machairiotis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Eirini Terzi; Bojan Zaric; Haidong Huang; Lutz Freitag; Dionysios Spyratos
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

4.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Authors:  Dimo Dietrich; Maria Jung; Svenja Puetzer; Annette Leisse; Emily Eva Holmes; Sebastian Meller; Barbara Uhl; Philipp Schatz; Claudia Ivascu; Glen Kristiansen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 5.  Molecular testing on serous effusion: An update.

Authors:  Saumya Sahu; Parikshaa Gupta; Pranab Dey
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

6.  Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.

Authors:  Krishna B Sriram; Vandana Relan; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Rayleen V Bowman; Kwun M Fong
Journal:  BMC Cancer       Date:  2012-09-25       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.